Furthermore, complement C3, C3a, C4, C4a, and C7 have been identified as biomarkers in HCC diagnosis while C7 and CFH are recognized for their critical roles in mediating stemness of tumor-initiating cells. The gene discussed is C3; the disease is neoplasm.